Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials


Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical trials, offering a unified platform for all data collection and management needs.

Over 50 percent of clinical trials involve medical imaging, yet a majority of sponsors and CROs report problems integrating imaging data into EDC systems. CDS has eliminated this challenge by building TrialKit PACS into the TrialKit eClinical platform. TrialKit PACS streamlines medical image capture into EDC trials by eliminating the time and cost of third party systems licensing and integration. Key benefits include:

"TrialKit PACS empowers researchers by simplifying the entire medical imaging process in clinical trials," said Jeff Rogers, President at CDS. "From secure image upload and anonymization to streamlined endpoint adjudication, automated notifications and error checks, TrialKit PACS offers a seamless experience within a single data collection platform."

To learn more about how TrialKit PACS can transform your clinical trial imaging processes, contact CDS: https://crucialdatasolutions.com/contact-us/.

About Crucial Data Solutions

Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative data collection and clinical trial management technology on the market today. TrialKit, our cloud-based platform available via both a web and native mobile app, enables end-to-end trial management for medical device, diagnostics, digital therapeutics, and biotechnology companies of all sizes. Design and deploy validated studies in days not weeks using our intuitive study builder that requires no programming. Thousands of global users have leveraged the flexibility of TrialKit to deploy over 8,000 studies across all phases of development.


These press releases may also interest you

at 22:51
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: